Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
We conduct clinical research and investigations to improve our ability to diagnose and treat patients with all genitourinary malignancies. This research is important, because it aims to improve current and future cancer treatments and care.
Our physicians and researchers conduct ongoing research studies, including:
If you are a new patient, we may ask you to participate in one of these studies.
Learn more about participating in a clinical trial.
As a Dana-Farber patient, you may be asked to participate in a research study designed to help doctors and scientists understand the basic biology and genetics of prostate and renal cancer, which ultimately may help people in the future.
During your appointment, a study coordinator will meet with you to discuss the study and answer your questions. Your participation is completely voluntary and will not affect your medical care or benefits should you decide not to participate.
Find out more about prostate, bladder, and kidney cancer research studies.
With the cooperation of more than 8,000 patients, the Arthur and Linda Gelb Center for Translational Research has steadily built a deep clinical database and collection of genitourinary tumor samples.
Research using these samples has yielded significant data about the development and treatment of prostate, kidney, and bladder cancers, helping scientists study possible links between genes and genitourinary cancers.
Such efforts are designed to develop better, more effective treatments for cancer and related malignancies.
Learn more about the Gelb Center.
New Patient Appointments
Clinical Trials Questions?